Milestone Scientific, Inc. (MLSS) vs Nephros Inc. (NEPH)

Milestone Scientific, Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $38.1M against $29.6M — 1.3× the size. Milestone Scientific, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 23.4×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against 3.72%. Nephros Inc. has the higher net margin (8.38% vs −44.0%) and the higher return on invested capital (14.1% vs −136.2%). Across the 18 metrics below, Nephros Inc. leads on 17 and Milestone Scientific, Inc. on 1.

Valuation

Metric MLSS NEPH Medical Instruments & Supplies median
P/E n/m 23.43 33.75
P/S 3.26 1.91 2.52
P/B 8.85 3.31 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m 19.82 14.62
EV/Sales 3.09 1.69 2.88
Earnings yield (13.33%) 4.27% (2.67%)
Free cash flow yield (2.78%) (1.98%) 0.09%

Profitability

Metric MLSS NEPH Medical Instruments & Supplies median
Gross margin 70.23% 61.26% 54.29%
Operating margin (43.56%) 7.92% 1.07%
Net margin (43.98%) 8.38% (1.61%)
Free cash flow margin (6.98%) (3.19%) 1.08%
Return on equity (121.68%) 16.10% (1.32%)
Return on assets (50.54%) 12.39% 0.00%
Return on invested capital (136.16%) 14.11% 0.00%

Growth

Metric MLSS NEPH Medical Instruments & Supplies median
Revenue growth (TTM) 3.72% 24.20% 8.85%
EPS growth (last fiscal year) (16.67%) 1,471.43% 8.65%
Revenue growth, 5-year CAGR 10.54% 17.02% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLSS NEPH Medical Instruments & Supplies median
Debt to equity 0.14 0.00 0.10
Current ratio 1.85 4.07 2.48
Net debt to EBITDA 0.05 (4.20) 0.89

Dividend

Metric MLSS NEPH Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric MLSS NEPH Medical Instruments & Supplies median
Market cap 29.61m 38.12m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack